Purple Biotech Net Asset Quality Index

Latest as of June 2026: 86.2%

Purple Biotech net asset quality index. Purple Biotech (PPBT) has a Net Asset Quality Index of 86.2% as of June 2026. This metric measures the proportion of total assets financed by shareholders' equity — total assets of $14.17 Million minus total liabilities of $1.95 Million yields net assets of $12.21 Million. A higher index indicates a stronger, lower-leverage balance sheet. See PPBT total equity for net asset value and shareholders' equity analysis.

Quality Index

86.2%
Equity / Total Assets

Net Assets

$12.21 Million
USD

Total Assets

$14.17 Million
USD

Total Liabilities

$1.95 Million
USD

Net Asset Quality Index of Purple Biotech (2013–2025)

Net asset quality index of Purple Biotech from 2013 to 2025. This chart shows how Purple Biotech's Net Asset Quality Index has evolved across 13 annual periods from 2013 to 2025. As of June 2026, the index stands at 86.2%, representing net assets of $12.21 Million against total assets of $14.17 Million USD. Check strategic asset allocation of Purple Biotech to assess the company's strategic physical and investment asset allocation.

Purple Biotech Net Asset Quality Index by Year (2013–2025)

Purple Biotech net asset quality index by year from 2013 to 2025. The table below presents the year-by-year Net Asset Quality Index for Purple Biotech from 2013 to 2025, covering 13 annual filings. Each row shows total assets, total liabilities, net assets, the quality index percentage, and the change in percentage points compared to the prior year. For live market cap and overall valuation, see Purple Biotech stock valuation.

Year Quality Index Net Assets (USD) Total Assets Total Liabilities Change (pp)
2025 55.0% $9.66 Million $17.57 Million $7.91 Million ▼ -33.9 pp
2024 88.9% $32.91 Million $37.04 Million $4.13 Million ▲ +11.4 pp
2023 77.4% $34.30 Million $44.30 Million $10.01 Million ▼ -8.8 pp
2022 86.2% $47.10 Million $54.62 Million $7.52 Million ▼ -6.5 pp
2021 92.7% $65.11 Million $70.20 Million $5.09 Million ▼ -2.4 pp
2020 95.2% $79.75 Million $83.80 Million $4.05 Million ▲ +21.4 pp
2019 73.8% $10.86 Million $14.72 Million $3.86 Million ▼ -0.9 pp
2018 74.7% $11.00 Million $14.72 Million $3.72 Million ▲ +14.2 pp
2017 60.6% $8.59 Million $14.18 Million $5.59 Million ▼ -29.2 pp
2016 89.7% $13.38 Million $14.91 Million $1.53 Million ▲ +2.5 pp
2015 87.2% $9.43 Million $10.81 Million $1.38 Million ▲ +43.3 pp
2014 43.9% $773.00K $1.76 Million $986.00K ▲ +348.1 pp
2013 -304.2% $-946.00K $311.00K $1.26 Million —
pp = percentage points